📰 Concomitant Use News
Page 2 - Concomitant Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Concomitant Use. Real-time updates on events, politics, business and more.
September 10, 2023
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant...
September 10, 2023
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant medication in pediatric patients with...
August 28, 2023
STOUGHTON, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutic...
August 21, 2023
THE WOODLANDS, Texas, Aug. 21, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that analyses of clinical study results relating to INPEFA™ , its recently approved drug for heart...
July 28, 2023
THE WOODLANDS, Texas, July 28, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that Diane E. Sullivan has been elected to its Board of Directors. Ms. Sullivan brings extensive...
June 30, 2023
DUBLIN, June 29, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Mercks Noxafil® in the U.S., followi...
June 29, 2023
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18...
June 15, 2023
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total occurrence of... | June 15, 2023
May 26, 2023
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes ...
December 1, 2022
21 scientific presentations, including 7 late breakers, showcase the breadth of UCBs portfolio, reinforcing commitment to improving the lives of people living...